MBM Wealth Consultants LLC Has $279,000 Holdings in CME Group Inc. (NASDAQ:CME)

22 Jan 2025, 09:44 by Renee Jackson · The Cerbat Gem

MBM Wealth Consultants LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,201 shares of the financial services provider’s stock after acquiring an additional 83 shares during the period. MBM Wealth Consultants LLC’s holdings in CME Group were worth $279,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in CME. Truvestments Capital LLC acquired a new stake in shares of CME Group in the third quarter valued at about $26,000. Dunhill Financial LLC grew its holdings in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after buying an additional 81 shares during the last quarter. Fortitude Family Office LLC grew its holdings in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its position in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares during the period. Finally, Anchor Investment Management LLC lifted its holdings in shares of CME Group by 52.4% during the third quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock worth $83,000 after buying an additional 130 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other news, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the transaction, the insider now owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. This trade represents a 14.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the transaction, the director now owns 10,589 shares in the company, valued at $2,403,279.44. This represents a 8.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,274 shares of company stock worth $1,648,071. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Down 0.2 %

Shares of CME opened at $232.25 on Wednesday. The company has a market capitalization of $83.69 billion, a P/E ratio of 24.42, a PEG ratio of 5.28 and a beta of 0.56. CME Group Inc. has a one year low of $190.70 and a one year high of $249.02. The business’s 50 day simple moving average is $233.43 and its 200-day simple moving average is $220.35. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 earnings per share. The business’s revenue was up 18.4% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 10.18 EPS for the current fiscal year.

CME Group declared that its board has authorized a stock buyback program on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

CME Group Increases Dividend

The business also recently disclosed a dividend, which was paid on Thursday, January 16th. Shareholders of record on Friday, December 27th were issued a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is a positive change from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio is currently 48.37%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on CME shares. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research report on Tuesday, October 8th. Bank of America increased their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft lowered their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Barclays raised their price objective on CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a research report on Monday, December 9th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research report on Monday, January 6th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $229.27.

Get Our Latest Report on CME

CME Group Company Profile

(Free Report)